FDA and Wireless Industry to Study Cell Phone Safety in Joint Project

Publication
Article
Oncology NEWS InternationalOncology NEWS International Vol 9 No 8
Volume 9
Issue 8

ROCKVILLE, Md-The FDA and the Cellular Telecommunications Industry Association (CTIA) have joined in a collaborative effort to examine the potential health effects of wireless telephones. FDA will provide research recommendations and oversight. CTIA will fund the studies, which will be done over the next 3 to 5 years by researchers who are not connected with FDA or the industry. Initial studies will focus on whether radiofrequent emissions from wireless phones pose any health threat. They will include both laboratory work and studies of mobile phone users.

ROCKVILLE, Md—The FDA and the Cellular Telecommunications Industry Association (CTIA) have joined in a collaborative effort to examine the potential health effects of wireless telephones. FDA will provide research recommendations and oversight. CTIA will fund the studies, which will be done over the next 3 to 5 years by researchers who are not connected with FDA or the industry. Initial studies will focus on whether radiofrequent emissions from wireless phones pose any health threat. They will include both laboratory work and studies of mobile phone users.

Newsletter

Stay up to date on recent advances in the multidisciplinary approach to cancer.

Recent Videos
4 experts in this video
2 experts in this video
2 experts in this video
4 experts in this video
Ongoing studies seek to evaluate immunotherapy in earlier lines of therapy for patients with early-stage Hodgkin lymphoma.
Strict inclusion criteria may disproportionately exclude racial minority populations from participating in breast cancer trials.
A paucity of prospective, well-vetted data to guide therapy in patients with rare lymphomas may result in a reliance on expert consensus guidelines.
Related Content